Jakob Lindberg

Biography

 Jakob Lindberg, M.D. has been Chief Executive Officer (CEO) of Oncopeptides AB since 2011. Jakob is a Venture Partner at Patricia Industries, part of the Investor AB group of companies. Jakob’s previous roles include being an analyst for Merrill Lynch & Co and a consultant at McKinsey&Co. Jakob also co-founded Cellectricon, a provider of cell-based screening services to accelerate drug discovery, where he also served as CEO. Jakob studied medicine at the Karolinska Institute where he also gained a Med Lic in Molecular Immunology and a MSc in pre-clinical medicine. He also has a BA in Finance and Administration from Stockholm University. He is Director of Affibody Medical AB, Alligator Bioscience AB, Atlas Antibodies AB, Dipylon Medical AB, Lindberg Life-Science AB and Bostadsrattsforeningen Astraea. He also serves as Alternate Director of Oncopeptides Incentive AB and CEO of Lindberg Life-Science AB.

Research Interest

 molecular immunology accounting